DENTSPLY SIRONA (NASDAQ:XRAY) Issues FY24 Earnings Guidance

DENTSPLY SIRONA (NASDAQ:XRAY) updated its FY24 earnings guidance on Wednesday. The company provided EPS guidance of $1.96 to $2.02 for the period, compared to the consensus EPS estimate of $2.01. The company issued revenue guidance of $3.86 billion to $3.90 billion, compared to the consensus revenue estimate of $3.92 billion. DENTSPLY SIRONA also updated its FY 2024 guidance to 1.960-2.020 EPS.

Wall Street Analyst Weigh In

Several brokerages have commented on XRAY. The Goldman Sachs Group dropped their target price on shares of DENTSPLY SIRONA from $34.00 to $30.00 and set a neutral rating on the stock in a report on Monday, May 6th. Piper Sandler restated a neutral rating and set a $32.00 target price (down from $35.00) on shares of DENTSPLY SIRONA in a report on Friday, May 3rd. Barrington Research reaffirmed an outperform rating and set a $38.00 price target on shares of DENTSPLY SIRONA in a research note on Monday, July 8th. Stifel Nicolaus decreased their price target on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a hold rating for the company in a research note on Thursday, July 18th. Finally, Evercore ISI decreased their price target on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an outperform rating for the company in a research note on Tuesday, July 9th. Five investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, DENTSPLY SIRONA currently has a consensus rating of Moderate Buy and a consensus target price of $33.44.

DENTSPLY SIRONA Stock Performance

XRAY stock traded down $1.24 during midday trading on Friday, reaching $25.49. 5,126,032 shares of the company were exchanged, compared to its average volume of 2,767,748. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.33 and a quick ratio of 0.97. The business has a 50-day moving average price of $26.18 and a two-hundred day moving average price of $30.08. DENTSPLY SIRONA has a one year low of $23.94 and a one year high of $40.92. The firm has a market capitalization of $5.17 billion, a price-to-earnings ratio of -57.93, a price-to-earnings-growth ratio of 1.28 and a beta of 1.01.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The firm had revenue of $984.00 million for the quarter, compared to analyst estimates of $993.61 million. During the same period in the prior year, the business posted $0.51 EPS. The firm’s quarterly revenue was down 4.3% compared to the same quarter last year. Equities research analysts forecast that DENTSPLY SIRONA will post 1.99 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 11th. Stockholders of record on Friday, September 27th will be issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.51%. The ex-dividend date of this dividend is Friday, September 27th. DENTSPLY SIRONA’s dividend payout ratio is currently -145.45%.

Insider Transactions at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier purchased 3,577 shares of the company’s stock in a transaction that occurred on Friday, May 31st. The stock was acquired at an average price of $27.95 per share, with a total value of $99,977.15. Following the completion of the purchase, the director now directly owns 58,374 shares in the company, valued at $1,631,553.30. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.52% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.